Halsey Associates’s Core Laboratories CLB Stock Holding History

Halsey Associates’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.68M	Buy	35,955 +2,182	+6%	+$101K	0.27%	55
2019 Q2	$1.77M	Buy	33,773 +3,248	+11%	+$191K	0.32%	52
2019 Q1	$2.1M	Buy	30,525 +442	+1%	+$29.6K	0.35%	50
2018 Q4	$1.79M	Sell	30,083 -29,972	-50%	-$2.59M	0.34%	51
2018 Q3	$6.96M	Buy	60,055 +16	+0%	+$1.8K	1.24%	32
2018 Q2	$7.58M	Sell	60,039 -1,842	-3%	-$224K	1.47%	27
2018 Q1	$6.7M	Sell	61,881 -759	-1%	-$84K	1.18%	32
2017 Q4	$6.86M	Buy	62,640 +2,395	+4%	+$239K	1.17%	34
2017 Q3	$5.95M	Buy	+60,245	New	+$5.84M	1.17%	36

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Halsey Associates's CLB Position: Q3 2019 in Review

Halsey Associates increased its Core Laboratories (CLB) stake by 6.5% in Q3 2019, buying an estimated $101K and bringing the position to 35,955 shares worth $1.68M. The position accounts for 0.27% of the portfolio, ranked #55.

Halsey Associates first reported a position in CLB in Q3 2017 and has held it in 9 quarters since. The position peaked at $7.58M in Q2 2018. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

Halsey Associates held 35,955 shares of Core Laboratories worth $1.68M as of Q3 2019.
Halsey Associates bought 2,182 Core Laboratories shares in Q3 2019, an estimated $101K.
Core Laboratories made up 0.27% of Halsey Associates's portfolio in Q3 2019, its #55 holding.
Halsey Associates first reported a position in Core Laboratories in Q3 2017 and has held it in 9 quarters since.
Halsey Associates's Core Laboratories position peaked at $7.58M in Q2 2018.
274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Halsey Associates's 13F filing for Q3 2019, filed 15 Nov 2019.